Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06120231 · ClinicalTrials.gov registry record · NA
Pulse-Width Modulation
A NA study of Spinal Fusion and Spinal Stenosis, sponsored by Dartmouth-Hitchcock Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06120231: Recruiting NA study of Spinal Fusion and Spinal Stenosis, sponsored by Dartmouth-Hitchcock Medical Center.
NCT06120231 is a NA study of Spinal Fusion and Spinal Stenosis that is actively recruiting participants, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 50 participants, below the 481-participant average among 19 other Spinal Fusion trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06120231, a NA study of Spinal Fusion and Spinal Stenosis, is actively recruiting participants, sponsored by Dartmouth-Hitchcock Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The overarching aim of this project is to modulate the pulse-width during stimulation of pedicle screws and record the response thresholds associated with each PWM setting. During this initial phase of the investigation, no further data will be collected.
Primary Outcome
Upon completion of the pedicle screw placements, each screw will be stimulated utilizing three different pulse-width settings, 0.4 milliseconds, 0.2 milliseconds, and 0.05 milliseconds. The stimulation intensity required to elicit a compound muscle action potential (CMAP) will be recorded for each pulse-width parameter. This is measured in microvolts (uV).
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Pulse width modulation
Study Locations (1)
New Hampshire
- Dartmouth-Health - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-12-01 |
| Est. Completion | 2027-06-01 |
| Phase | NA |
What NCT06120231 shows while recruiting
NCT06120231 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 481-participant average among 19 other Spinal Fusion trials with a reported enrollment target (90% lower).
The record links to 2 conditions, with Spinal Fusion appearing as the primary indexed condition, and to 1 intervention - of which Pulse width modulation is the first listed.
NCT06120231 reports a single indexed study location in New Hampshire.
Frequently Asked Questions
What is clinical trial NCT06120231 about?
NCT06120231 is a clinical study titled "Pulse-Width Modulation". The overarching aim of this project is to modulate the pulse-width during stimulation of pedicle screws and record the response thresholds associated with each PWM setting. During this initial phase of the investigation, no further data will be collected.
What is the current status of trial NCT06120231?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-12-01. Estimated completion is 2027-06-01.
What conditions does trial NCT06120231 study?
This clinical trial studies the following conditions: Spinal Fusion, Spinal Stenosis.
What interventions are being tested in trial NCT06120231?
The interventions under investigation include: Pulse width modulation (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06120231?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06120231 being conducted?
This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Fusion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06120231's enrollment target sits among peer trials
50 14th of 19 higher than 3 of 19 other Spinal Fusion trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Fusion trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Photobiomodulation for Lower Back Pain Post Spinal Fusion and Decompression Surgery
RECRUITING · NA
-
Kids With Iron Deficiency and Scoliosis
RECRUITING · NA
-
Trans-Auricular Stimulation for Postoperative Inflammation in Spine Surgery
RECRUITING · NA
-
Postoperative Pain Control in AIS Using Liposomal Bupivacaine vs. 0.25% Bupivacaine With Epinephrine
RECRUITING · NA
-
Lumbar Fusion With Porous Versus Non-Porous Cages
ACTIVE NOT RECRUITING · NA
-
Alvimopan and Ileus in PSF
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI